MicroRNAs function as tumor suppressors or oncogenes: Aberrant expression of microRNAs in head and neck squamous cell carcinoma

Auris Nasus Larynx

Volumn 40, Issue 2, 2013, Pages 143-149

  Nohata, Nijiro ^a   Hanazawa, Toyoyuki ^a   Kinoshita, Takashi ^a   Okamoto, Yoshitaka ^a   Seki, Naohiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Head and neck squamous cell carcinoma; MiRNA; MiRNA expression profiles; Tumor suppressor

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 125A; MICRORNA 16; MICRORNA 181A; MICRORNA 181B; MICRORNA 200A; MICRORNA 200C; MICRORNA 21; MICRORNA 26A; MICRORNA 31; MICRORNA 344; MICRORNA 34A; MICRORNA 375; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BIOINFORMATICS; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; DISEASE MARKER; DOWN REGULATION; DRUG TARGETING; EARLY CANCER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPLACEMENT THERAPY; GENE REPRESSION; GENETIC VARIABILITY; GENOME ANALYSIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MAXILLA SINUS CARCINOMA; METASTASIS; MINIMALLY INVASIVE PROCEDURE; MOLECULAR DIAGNOSIS; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PROSTATE CANCER; REVIEW; RNA CLEAVAGE; RNA GENE; RNA SEQUENCE; RNA SYNTHESIS; RNA TRANSCRIPTION; TRANSLATION REGULATION; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MICRORNAS; ONCOGENES; TRANSCRIPTOME; UP-REGULATION;

EID: 84875377431     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2012.07.001     Document Type: Review

References (102)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003, 260:502-508.
3. Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11:9-22.
4. Perez-Ordonez B., Beauchemin M., Jordan R.C. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 2006, 59:445-453.
5. Chung C.H., Gillison M.L. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 2009, 15:6758-6762.
6. Gasco M., Crook T. The p53 network in head and neck cancer. Oral Oncol 2003, 39:222-231.
7. Lopez F., Llorente J.L., Garcia-Inclan C., Alonso-Guervos M., Cuesta-Albalad M.P., Fresno M.F., et al. Genomic profiling of sinonasal squamous cell carcinoma. Head Neck 2011, 33:145-153.
8. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006, 11:441-450.
9. Garzon R., Calin G.A., Croce C.M. MicroRNAs in Cancer. Annu Rev Med 2009, 60:167-179.
10. Nelson K.M., Weiss G.J. MicroRNAs and cancer: past, present, and potential future. Mol Cancer Therap 2008, 7:3655-3660.
11. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060.
12. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
13. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531.
14. Kwak P.B., Iwasaki S., Tomari Y. The microRNA pathway and cancer. Cancer Sci 2010, 101:2309-2315.
15. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
16. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529.
17. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004, 101:2999-3004.
18. Avissar M., Christensen B.C., Kelsey K.T., Marsit C.J. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009, 15:2850-2855.
19. Childs G., Fazzari M., Kung G., Kawachi N., Brandwein-Gensler M., McLemore M., et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009, 174:736-745.
20. Hui A.B., Lenarduzzi M., Krushel T., Waldron L., Pintilie M., Shi W., et al. Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010, 16:1129-1139.
21. Kikkawa N., Hanazawa T., Fujimura L., Nohata N., Suzuki H., Chazono H., et al. miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br J Cancer 2010, 103:877-884.
22. Lajer C.B., Nielsen F.C., Friis-Hansen L., Norrild B., Borup R., Garnaes E., et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer 2011, 104:830-840.
23. Liu C.J., Tsai M.M., Hung P.S., Kao S.Y., Liu T.Y., Wu K.J., et al. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 2010, 70:1635-1644.
24. Nohata N., Hanazawa T., Kikkawa N., Sakurai D., Fujimura L., Chiyomaru T., et al. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br J Cancer 2011, 105:833-841.
25. Wong T.S., Liu X.B., Wong B.Y., Ng R.W., Yuen A.P., Wei W.I. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008, 14:2588-2592.
26. Pan X., Wang Z.X., Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther 2011, 10:1224-1232.
27. Chang S.S., Jiang W.W., Smith I., Poeta L.M., Begum S., Glazer C., et al. MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 2008, 123:2791-2797.
28. Zhang X., Cairns M., Rose B., O'Brien C., Shannon K., Clark J., et al. Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer 2009, 124:2855-2863.
29. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
30. Zhu S., Si M.L., Wu H., Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007, 282:14328-14336.
31. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008, 283:1026-1033.
32. Papagiannakopoulos T., Shapiro A., Kosik K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008, 68:8164-8172.
33. Cervigne N.K., Reis P.P., Machado J., Sadikovic B., Bradley G., Galloni N.N., et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 2009, 18:4818-4829.
34. Li J., Huang H., Sun L., Yang M., Pan C., Chen W., et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009, 15:3998-4008.
35. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 2009, 1792:497-505.
36. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261.
37. Szafranska A.E., Davison T.S., John J., Cannon T., Sipos B., Maghnouj A., et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26:4442-4452.
38. Wang X., Tang S., Le S.Y., Lu R., Rader J.S., Meyers C., et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008, 3:e2557.
39. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
40. Valastyan S., Weinberg R.A. miR-31: a crucial overseer of tumor metastasis and other emerging roles. Cell Cycle 2010, 9:2124-2129.
41. Zhang L., Huang J., Yang N., Greshock J., Megraw M.S., Giannakakis A., et al. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006, 103:9136-9141.
42. Schaefer A., Jung M., Mollenkopf H.J., Wagner I., Stephan C., Jentzmik F., et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 2010, 126:1166-1176.
43. Creighton C.J., Fountain M.D., Yu Z., Nagaraja A.K., Zhu H., Khan M., et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res 2010, 70:1906-1915.
44. Bandres E., Cubedo E., Agirre X., Malumbres R., Zarate R., Ramirez N., et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006, 5:29.
45. Motoyama K., Inoue H., Takatsuno Y., Tanaka F., Mimori K., Uetake H., et al. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009, 34:1069-1075.
46. Wong Q.W., Lung R.W., Law P.T., Lai P.B., Chan K.Y., To K.F., et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 2008, 135:257-269.
47. Gottardo F., Liu C.G., Ferracin M., Calin G.A., Fassan M., Bassi P., et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007, 25:387-392.
48. Mathe E.A., Nguyen G.H., Bowman E.D., Zhao Y., Budhu A., Schetter A.J., et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009, 15:6192-6200.
49. Li X., Zhang Y., Zhang Y., Ding J., Wu K., Fan D. Survival prediction of gastric cancer by a seven-microRNA signature. Gut 2010, 59:579-585.
50. Earle J.S., Luthra R., Romans A., Abraham R., Ensor J., Yao H., et al. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J Mol Diagn 2010, 12:433-440.
51. Mi S., Lu J., Sun M., Li Z., Zhang H., Neilly M.B., et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA 2007, 104:19971-19976.
52. Stamatopoulos B., Meuleman N., Haibe-Kains B., Saussoy P., Van Den Neste E., Michaux L., et al. MicroRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009, 113:5237-5245.
53. Miko E., Czimmerer Z., Csanky E., Boros G., Buslig J., Dezso B., et al. Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 2009, 35:646-664.
54. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
55. Poy M.N., Hausser J., Trajkovski M., Braun M., Collins S., Rorsman P., et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci USA 2009, 106:5813-5818.
56. Kong K.L., Kwong D.L., Chan T.H., Law S.Y., Chen L., Li Y., et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2012, 61:33-42.
57. Li X., Lin R., Li J. Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci 2011, 56:2849-2856.
58. Liu A.M., Poon R.T., Luk J.M. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 2010, 394:623-627.
59. Tsukamoto Y., Nakada C., Noguchi T., Tanigawa M., Nguyen L.T., Uchida T., et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 2010, 70:2339-2349.
60. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Sakurai D., Fujimura L., et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 2011, 56:595-601.
61. Kinoshita T., Nohata N., Yoshino H., Hanazawa T., Kikkawa N., Fujimura L., et al. Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int J Oncol 2012, 40:185-193.
62. Hui A.B., Bruce J.P., Alajez N.M., Shi W., Yue S., Perez-Ordonez B., et al. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res 2011, 17:7539-7550.
63. He X.X., Chang Y., Meng F.Y., Wang M.Y., Xie Q.H., Tang F., et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012, 31:3357-3369.
64. Basu A., Alder H., Khiyami A., Leahy P., Croce C.M., Haldar S. MicroRNA-375 and microRNA-221: potential noncoding RNAs associated with antiproliferative activity of benzyl isothiocyanate in pancreatic cancer. Genes Cancer 2011, 2:108-119.
65. Kawakami K., Enokida H., Chiyomaru T., Tatarano S., Yoshino H., Kagara I., et al. The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer 2012, 48:827-836.
66. Kojima S., Chiyomaru T., Kawakami K., Yoshino H., Enokida H., Nohata N., et al. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer 2012, 106:405-413.
67. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Fujimura L., Yoshino H., et al. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int J Oncol 2011, 38:209-217.
68. Nohata N., Hanazawa T., Kikkawa N., Sakurai D., Sasaki K., Chiyomaru T., et al. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Int J Oncol 2011, 39:1099-1107.
69. Nohata N., Sone Y., Hanazawa T., Fuse M., Kikkawa N., Yoshino H., et al. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2011, 2:29-44.
70. Yoshino H., Chiyomaru T., Enokida H., Kawakami K., Tatarano S., Nishiyama K., et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 2011, 104:808-818.
71. Nohata N., Hanazawa T., Enokida H., Seki N. MicroRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 2012, 3:9-21.
72. Kinoshita T., Nohata N., Watanabe-Takano H., Yoshino H., Hidaka H., Fujimura L., et al. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma. Int J Oncol 2012, 40:1770-1778.
73. Mutallip M., Nohata N., Hanazawa T., Kikkawa N., Horiguchi S., Fujimura L., et al. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133alpha in head and neck squamous cell carcinoma (HNSCC). Int J Mol Med 2011, 27:345-352.
74. Kinoshita T., Nohata N., Fuse M., Hanazawa T., Kikkawa N., Fujimura L., et al. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun 2012, 418:378-383.
75. Nam E.J., Yoon H., Kim S.W., Kim H., Kim Y.T., Kim J.H., et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 2008, 14:2690-2695.
76. Yamada H., Yanagisawa K., Tokumaru S., Taguchi A., Nimura Y., Osada H., et al. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer. Genes Chromosomes Cancer 2008, 47:810-818.
77. Petrelli A., Perra A., Schernhuber K., Cargnelutti M., Salvi A., Migliore C., et al. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. Oncogene 2012, 10.1038/onc.2011.631.
78. Hwang K.T., Han W., Cho J., Lee J.W., Ko E., Kim E.K., et al. Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer 2008, 123:1807-1815.
79. Iizuka M., Sugiyama Y., Shiraishi M., Jones C., Sekiya T. Allelic losses in human chromosome 11 in lung cancers. Genes Chromosomes Cancer 1995, 13:40-46.
80. Connolly K.C., Gabra H., Millwater C.J., Taylor K.J., Rabiasz G.J., Watson J.E., et al. Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer. Cancer Res 1999, 59:2806-2809.
81. Wilting S.M., Snijders P.J., Verlaat W., Jaspers A., van de Wiel M.A., van Wieringen W.N., et al. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 2012, 10.1038/onc.2012.20.
82. Kohno T., Kawanishi M., Matsuda S., Ichikawa H., Takada M., Ohki M., et al. Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma. Genes Chromosomes Cancer 1998, 21:236-243.
83. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
84. Yang C.C., Hung P.S., Wang P.W., Liu C.J., Chu T.H., Cheng H.W., et al. miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J Oral Pathol Med 2011, 40:397-404.
85. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008, 22:894-907.
86. Lo W.L., Yu C.C., Chiou G.Y., Chen Y.W., Huang P.I., Chien C.S., et al. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 2011, 223:482-495.
87. Cho W.C. Circulating microRNAs as minimally invasive biomarkers for cancer theragnosis and prognosis. Front Genet 2011, 2:7.
88. Kosaka N., Iguchi H., Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010, 101:2087-2092.
89. Liu C.J., Lin S.C., Yang C.C., Cheng H.W., Chang K.W. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck 2012, 34:219-224.
90. Park N.J., Zhou H., Elashoff D., Henson B.S., Kastratovic D.A., Abemayor E., et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009, 15:5473-5477.
91. Liu C.J., Kao S.Y., Tu H.F., Tsai M.M., Chang K.W., Lin S.C. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 2010, 16:360-364.
92. Lu Y.C., Chen Y.J., Wang H.M., Tsai C.Y., Chen W.H., Huang Y.C., et al. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res (Phila) 2012, 5:665-674.
93. Lin S.C., Liu C.J., Lin J.A., Chiang W.F., Hung P.S., Chang K.W. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol 2010, 46:204-208.
94. Chen K., Song F., Calin G.A., Wei Q., Hao X., Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 2008, 29:1306-1311.
95. Clague J., Lippman S.M., Yang H., Hildebrandt M.A., Ye Y., Lee J.J., et al. Genetic variation in microRNA genes and risk of oral premalignant lesions. Mol Carcinog 2010, 49:183-189.
96. Glinsky G.V. An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway. Cell Cycle 2008, 7:2570-2583.
97. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
98. Bader A.G., Brown D., Winkler M. The promise of microRNA replacement therapy. Cancer Res 2010, 70:7027-7030.
99. Esquela-Kerscher A., Trang P., Wiggins J.F., Patrawala L., Cheng A., Ford L., et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 2008, 7:759-764.
100. Wiggins J.F., Ruffino L., Kelnar K., Omotola M., Patrawala L., Brown D., et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 2010, 70:5923-5930.
101. Takeshita F., Patrawala L., Osaki M., Takahashi R.U., Yamamoto Y., Kosaka N., et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 2010, 18:181-187.
102. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.